Hwang TJ, Powers JH CKASD. Quantifying The Food and Drug Administration’s Rulemaking Delays Highlights The Need For Transparency. Health Affairs . 2014;33 (2).

Hwang TJ, Carpenter D KAS. Assessment of US pathway for approving medical devices for rare conditions. British Medical Journal. 2014.

Hwong AR, Qaragholi N CJCEGSLDSL. A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act. Journal of Law, Medicine & Ethics. 2014;42 (2).

D C. Accounting for Financial Innovation and Borrower Confidence in Financial Rulemaking: Analogies from Health Policy. Journal of Legal Studies. 2014;43 (S2).

Tai L CD. Strengths and Weaknesses in the Case for SEC Capture. Law and Financial Markets Review. 2014;8 (3).

Einhorn R, Schickler E, Anthony S. C. Studies in American Political Development. 2014.

Thomas J. S, Carpenter D, Aaron S. K. Target small firms for antibiotic innovation. Science. 2014;344 (6187) :967 - 969.

Carpenter D, Moore CD. When Canvassers Became Activists: Antislavery Petitioning and the Political Mobilization of American Women. American Political Science Review. 2014;108 (3) :479 - 498. whencanvassersbecameactivists-apsrpublishedaugust2014.pdf